● miR-92b suppressed CD69 on natural killer (NK) cells and predicted the risk of post-transplant HCC (hepatocellular carcinoma) recurrence (102); ● miR-92b was upregulated and could monitor chemoresistance in small lung cancer (103); ● miR-92b decreased in early CRC (colorectal cancer) cancer (104). The gene discussed is CD69; the disease is hepatocellular carcinoma.